Gastric cancer has been epidemiologically linked to infection with the bacterium Helicobacter pylori (HP). Mechanisms underlying this possible connection are unknown. In HP infection, chronic gastritis occurs, characterized by the activation of mucosal macrophages and other immune cells. In this inflamed tissue, resident and recruited immune cells may be activated directly by bacterial products or indirectly by intracellular signaling. With stimulation, nitric oxide (NO) can be abundantly produced by the inducible form of the enzyme NO synthase (iNOS) in many cell types, especially immune cells. Our preliminary data indicate that HP dramatically increases iNOS mRNA and NO production in macrophages. NO has been shown to possess mutagenic activity. We therefore hypothesize that one mechanism by which HP contributes to the development of gastric adenocarcinoma is the chronic upregulation of NO production in gastric mucosa. Our proposal will have two main Specific Aims: I) To discover mechanisms of HP-induced NO production in macrophages, and II) To demonstrate that HP-induced NO production contributes to gastric carcinogenesis. In order to accomplish Aim I, we will: A) prove that functional iNOS is directly induced by HP in macrophages by measuring I) production of nitrite, a stable metabolite of NO, 2) iNOS enzyme activity, 3) iNOS mRNA expression by Northern blotting, and 4) iNOS protein expression by Western blotting; B) identify and purify HP-derived factors mediating iNOS induction in macrophages; C) determine whether luminal HP stimulates gastric epithelial-to-macrophage signaling using 1) a co- culture model with HP-treated epithelial cells grown on semipermeable membrane supports above macrophages, and 2) HP-free conditioned media from HP-stimulated and control epithelial cells; and D) study the mechanism of HP-induced activation of iNOS in macrophages, specifically mechanisms of transcriptional regulation of iNOS.
For Aim II, we will: A) demonstrate mutagenic effects of NO on gastric epithelial cells, specifically microsatellite instability and mutations in the gastric cancer suppressor genes p53 and APC; B) correlate gastric mucosal iNOS gene expression with HP status in gastric biopsies of patients; and C) correlate in vivo HP status and iNOS expression with gastric carcinogenesis. To accomplish this last sub-Aim, we will: l) correlate HP serology with malignant tissue mutational events in gastric cancer patients from countries with relatively high (S. Korea) and low (U.S.A.) HP rates; 2) ascertain HP serology and tissue HP status, iNOS expression, and mutational events at discrete stages of gastric carcinogenesis, including active superficial gastritis, chronic atrophic gastritis, intestinal metaplasia of the stomach, gastric dysplasia, and frank adenocarcinoma. If iNOS induction participates in the initiation or progression of gastric cancer, an understanding of the factors mediating induction of iNOS by HP should provide insight into possible novel targets of pharmacologic intervention or prevention in gastric carcinogenesis as well as potential novel diagnostic markers of gastric neoplastic progression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA067497-03
Application #
2429854
Study Section
Special Emphasis Panel (SRC (24))
Program Officer
Hall, Leota
Project Start
1995-06-15
Project End
2000-05-31
Budget Start
1997-06-01
Budget End
2000-05-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Wilson, K T (2002) Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus. Dis Esophagus 15:16-21
Moriyama, H; Sasamoto, H; Kambara, T et al. (2002) E2F-4 mutation in hereditary non-polyposis colorectal cancer. J Exp Clin Cancer Res 21:185-9
Akhtar, M; Cheng, Y; Magno, R M et al. (2001) Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res 61:2399-403
Meyer, F; Wilson, K T; James, S P (2000) Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun 68:6265-72
Tamura, G; Yin, J; Wang, S et al. (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569-73
Biden, K G; Simms, L A; Cummings, M et al. (1999) Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability. Oncogene 18:1245-9
Souza, R F; Wang, S; Thakar, M et al. (1999) Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 18:4063-8
Fleisher, A S; Esteller, M; Wang, S et al. (1999) Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59:1090-5
Fu, S; Ramanujam, K S; Wong, A et al. (1999) Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116:1319-29
Simms, L A; Radford-Smith, G; Biden, K G et al. (1998) Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers. Oncogene 17:2003-8

Showing the most recent 10 out of 27 publications